Ipamorelin Therapy in Miami, FL

What Is Ipamorelin?

Ipamorelin is a synthetic pentapeptide (five amino acids) classified as a growth hormone-releasing peptide (GHRP). It stimulates the pituitary gland to produce and release human growth hormone (HGH) by binding to ghrelin receptors — also known as growth hormone secretagogue receptors (GHS-R) — on somatotroph cells in the anterior pituitary.

While several GHRPs exist, ipamorelin has emerged as the gold standard in modern anti-aging and regenerative medicine due to one defining characteristic: its exceptional selectivity. Ipamorelin stimulates growth hormone release with remarkable precision, producing minimal impact on other hormones that older GHRPs tend to elevate.

The Most Selective GHRP Available

To understand why ipamorelin's selectivity matters, it helps to compare it to earlier growth hormone-releasing peptides.

Older GHRPs like GHRP-6 and GHRP-2 are effective at stimulating growth hormone release, but they come with collateral effects. GHRP-6 causes significant increases in appetite (driven by ghrelin stimulation), elevates cortisol (a stress hormone that promotes fat storage and muscle breakdown), and raises prolactin levels. GHRP-2 is somewhat more selective than GHRP-6 but still produces meaningful cortisol and prolactin elevation at higher doses.

Ipamorelin solves these problems. Research has demonstrated that ipamorelin stimulates growth hormone release without significantly affecting cortisol, prolactin, or adrenocorticotropic hormone (ACTH). This means you get the growth hormone benefits without the unwanted side effects associated with cortisol elevation (fat storage, anxiety, immune suppression) or prolactin elevation (water retention, mood changes).

This selectivity also makes ipamorelin dose-friendly — growth hormone release increases proportionally with dose without a corresponding spike in stress hormones, giving clinicians a wider therapeutic window to work within.

CJC-1295 + Ipamorelin: The Gold Standard Combination

While ipamorelin is effective on its own, it reaches its full potential when combined with CJC-1295 — a modified GHRH analog that works through a completely different receptor pathway. This combination is the most commonly prescribed growth hormone peptide protocol at Rewind Anti-Aging of Miami and across the anti-aging field nationally.

The rationale is straightforward: dual-pathway synergy.

• CJC-1295 binds to GHRH receptors on the pituitary gland, mimicking the natural growth hormone-releasing hormone your hypothalamus produces. It increases the baseline signal that tells the pituitary to produce growth hormone
• Ipamorelin binds to ghrelin receptors on the pituitary gland, providing a second, independent signal for growth hormone release. It amplifies the pulse on top of CJC-1295's baseline elevation

When both pathways are activated simultaneously, the growth hormone response is significantly greater than either peptide alone — a true synergistic effect, not merely additive. Studies have confirmed that combining a GHRH analog with a GHRP produces GH pulses that are substantially larger and more sustained than single-agent therapy.

The CJC-1295 + ipamorelin combination also provides both sustained GH elevation (from CJC-1295's longer half-life) and amplified pulsatile release (from ipamorelin's ghrelin receptor stimulation). This produces a comprehensive growth hormone optimization response that addresses both the baseline and peak components of healthy GH secretion.

Benefits of Ipamorelin Therapy

By optimizing growth hormone production through the pituitary gland, ipamorelin — especially in combination with CJC-1295 — produces benefits across multiple body systems.

Sleep Quality

Improved sleep is consistently the first benefit patients report, often within one to two weeks. Growth hormone is released primarily during deep, slow-wave sleep, and enhanced GH production improves the quality and depth of this restorative sleep stage. Patients describe falling asleep more easily, sleeping through the night, experiencing more vivid dreams, and waking genuinely rested.

Lean Muscle Mass and Strength

Growth hormone is a potent driver of protein synthesis, muscle cell proliferation, and lean tissue development. Patients using ipamorelin — particularly those who combine it with regular resistance training — commonly report improved muscle tone, faster strength gains, and better workout performance. These effects develop progressively over two to six months.

Fat Loss and Body Composition

HGH promotes lipolysis — the breakdown of stored fat for energy — while simultaneously preserving lean tissue. Patients on ipamorelin therapy frequently see reductions in body fat percentage, particularly visceral abdominal fat, along with an improved waist-to-hip ratio. The body shifts toward using fat as fuel, producing a leaner, more metabolically healthy physique.

Recovery and Repair

Growth hormone accelerates tissue repair, reduces recovery time after exercise or injury, and supports joint and connective tissue health. Athletes and active adults on ipamorelin therapy report less muscle soreness after training, faster return to peak performance, and improved resilience against minor injuries.

Skin Health

HGH stimulates collagen and elastin production — the structural proteins responsible for skin firmness and elasticity. Patients commonly notice improved skin texture, reduced fine lines, better hydration, and an overall healthier complexion over the course of three to six months.

Side Effects of Ipamorelin

Ipamorelin's selectivity gives it one of the most favorable side effect profiles of any growth hormone peptide. Commonly reported effects are mild and typically transient.

• Increased hunger — ipamorelin acts on ghrelin receptors, which can produce a mild increase in appetite, particularly shortly after injection. This is less pronounced than with GHRP-6 but noticeable in some patients
• Water retention — mild fluid retention during the initial weeks of treatment. This typically normalizes as the body adjusts and is not clinically significant
• Tingling or numbness — occasional tingling in the hands or feet, related to increased growth hormone activity. Usually mild and resolves with dose adjustment if needed
• Headache — infrequent, and when present, usually mild and limited to the initial adjustment period
• Injection site irritation — minor redness or tenderness at the injection site, comparable to any subcutaneous injection

Because ipamorelin does not significantly elevate cortisol, prolactin, or ACTH, the hormonal side effects seen with older GHRPs — anxiety, water retention from prolactin, immune suppression — are largely absent. This clean side effect profile is the primary reason ipamorelin has become the preferred GHRP in clinical practice.

Administration

Ipamorelin is administered via subcutaneous injection, typically in the abdominal area or thigh, using a small insulin-type syringe. The injection is brief and minimally uncomfortable.

When used alone, ipamorelin is usually administered nightly before bedtime on an empty stomach — timed to coincide with the body's natural growth hormone release during deep sleep. When combined with CJC-1295, the dosing schedule may be adjusted based on the specific CJC-1295 formulation used (with or without DAC).

We teach every patient the injection technique during their onboarding visit at Rewind Anti-Aging. The process takes seconds, and most patients are fully comfortable with self-administration within the first few days.

Ipamorelin Therapy at Rewind Anti-Aging of Miami

Every ipamorelin protocol at our clinic begins with a consultation and baseline blood work, including IGF-1 (the primary marker for growth hormone status), a comprehensive metabolic panel, and other relevant markers. These results confirm that growth hormone optimization is appropriate for you and establish a baseline for measuring progress.

Follow-up labs are drawn at 8 to 12 weeks to assess your response. We adjust dosing based on your IGF-1 levels, symptom improvement, and subjective experience. Whether prescribed alone or as part of the CJC-1295 + ipamorelin combination, ipamorelin integrates seamlessly with our other optimization services including testosterone therapy, weight management, and comprehensive peptide therapy protocols.